Company intelligence / Profile preview

Cetero Research

Fargo, North Dakota, United Statesnlrb.gov ↗

Ownership: Private
Development stage: Other

Overview

Cetero Research was a leading early-phase contract research organization specializing in clinical pharmacology and bioanalytical services for small and large molecules. It supported clinical development across multiple therapeutic areas, offering innovative study designs to accelerate drug development timelines. The company ceased operations after bankruptcy and reorganization as PRACS Institute, which also subsequently closed.

Therapeutic areas: PulmonologyDermatologyImmunologyEndocrinology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Cetero Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetero Research.

Explore the full profile